Issue

A report recently released by the Association of American Medical Colleges, in cooperation with the Food and Drug Administration, calls for new and increased collaboration among pharmaceutical companies, academia, and regulators to help overcome obstacles to developing innovative diagnostics and therapeutics.

The essentials of designing, constructing, qualifying and operating a pharmaceutical cleanroom will be presented by internationally recognized contamination-control expert Dr. Hans Schicht at CleanRooms Puerto Rico, November 17, at the Wyndham Condado Plaza Hotel & Casino.

News snippets from the world of contamination control.

The potential for in-body and out-of-body applications for lab-on-a-chip technology is raising two entirely different kinds of contamination-control issues.

The Parenteral Drug Association is partnering with third-party pharmaceutical supply chain operations auditor SynTegra LLC to streamline and manage the association’s virtual Audit Resource Center.

Corrections to contamination-control issues that halted vaccine production last fall at Chiron Corp.’s Liverpool, U.K., facility are being met with general approval by the Food and Drug Administration, but it remains to be seen whether the manufacturer can fully satisfy regulatory requirements in time for the upcoming flu season.

FAIRBANKS, Alaska - The Office of Electronic Miniaturization at the University of Alaska Fairbanks has partnered with Tessera Technologies to use the company’s MicroBGA chip-scale packaging (CSP) technology for developing regional enterprise and government projects requiring reliable, industry-proven semiconductor packaging capabilities.

Semiconductor makers and tool suppliers, as well as cleanroom builders and operators, are beginning to understand the implications of what it will mean to “think green” in the near future.

Facilities requiring compliance with USP 797 can be placed into two broad categories: a cleanroom that supports higher air quality environments such as clean benches and biological safety cabinets; and barrier isolators, which are not required to be placed into a cleanroom.

The pharmaceutical/biotechnology industry is the second largest consumer of cleanroom space.

As an American citizen, I’m entitled to cast one vote each year at election time.

This Recommended Practice (RP) published by the Institute of Environmental Sciences and Technology (IEST) is considered essential for individuals in industries that might benefit from the use of localized, enhanced contamination control.

The processes resulting in the emission of particles from production utilities are those of friction and vibration.

The ever-changing body of rules and regulations governing operations of the pharmaceutical and biotech industry has required flexibility and adjustment of production facilities in order to comply with current and even proposed mandates.

Controlling bacteria is a top priority for food processors waging the war against foodborne illness. Devising an effective strategy-which will vary by product-is half the battle.

Each month, Cleanrooms brings you a collection of the latest product innovations in the contamination-control industry.

Building or renovating cleanroom space requires careful consideration of many factors and requirements, including airflow, temperature, humidity, and personnel interaction to name a few. Preplanning is crucial to a successful cleanroom project, which is why consulting with experienced design experts may be a wise idea. To help get you started, this month we’ve compiled a selection of highly qualified architecture firms specializing in the design and construction of cleanroom space.